Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Upadacitinib vs Placebo and Adalimumab in RA (SELECT-COMPARE)
NCT02629159Phase 3Active, not recruiting
- Sponsor
- AbbVie Inc.
- Start
- Dec 2015
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 44
01
Overview
A Phase 3 trial of upadacitinib in rheumatoid arthritis (RA), sponsored by AbbVie Inc.. Started Dec 2015; status: active, not recruiting.
02
Drugs
upadacitinib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02629159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02629159.